Javascript must be enabled to continue!
Comparison between the PaxView TB/NTM MPCR-ULFA Kit and Xpert MTB/RIF for Mycobacterium Tuberculosis Detection in Indonesian Clinical Isolates
View through CrossRef
The PaxView TB/NTM MPCR-ULFA Kit, which targets the IS6110 and mtp40 genes for Mycobacteriumtuberculosis (MTB) detection, is a novel tool that substitutes gel electrophoresis for universal lateral flowassays. The sensitivity and specificity of this method were compared with those of established methodologiesusing Indonesian clinical isolates. In this study, 317 sputum specimens isolated from tuberculosis (TB)suspects were examined to evaluate the performance of the PaxView TB/NTM MPCR-ULFA Kit comparedto that of smear microscopy and the Xpert MTB/RIF assay. Out of 317 cases, the rate of TB-positivesamples evaluated by different methods was 33.4% (106/317; 95% CI 28.2-38.6) for smear microscopy,37.9% (120/317; 95% CI 32.5-43.2) for the Xpert MTB/RIF, and 40.7% (129/317; 95% CI 35.3-46.1) forthe PaxView TB/NTM MPCR-ULFA Kit. Compared to the Xpert MTB/RIF as a standard reference, thePaxView TB/NTM MPCR-ULFA Kit was found to possess a 92.5% sensitivity (111/120; 95% CI 87.8-97.2), a 90.8% specificity (179/197; 95% CI 86.8-94.8), 86.0% PPV (111/129; 95% CI 80.0-92.0), anda NPV 95.2% (179/188; 95% CI 92.2-98.3). The PaxView TB/NTM MPCR-ULFA Kit could be a usefulmolecular diagnostic tool to identify MTB in clinical samples in resource-limited countries, as this procedureis more cost-effective and sensitive than the Xpert MTB/RIF, and more convenient than conventional PCRgel electrophoresis approaches.
Institute of Medico-legal Publications Private Limited
Title: Comparison between the PaxView TB/NTM MPCR-ULFA Kit and Xpert MTB/RIF for Mycobacterium Tuberculosis Detection in Indonesian Clinical Isolates
Description:
The PaxView TB/NTM MPCR-ULFA Kit, which targets the IS6110 and mtp40 genes for Mycobacteriumtuberculosis (MTB) detection, is a novel tool that substitutes gel electrophoresis for universal lateral flowassays.
The sensitivity and specificity of this method were compared with those of established methodologiesusing Indonesian clinical isolates.
In this study, 317 sputum specimens isolated from tuberculosis (TB)suspects were examined to evaluate the performance of the PaxView TB/NTM MPCR-ULFA Kit comparedto that of smear microscopy and the Xpert MTB/RIF assay.
Out of 317 cases, the rate of TB-positivesamples evaluated by different methods was 33.
4% (106/317; 95% CI 28.
2-38.
6) for smear microscopy,37.
9% (120/317; 95% CI 32.
5-43.
2) for the Xpert MTB/RIF, and 40.
7% (129/317; 95% CI 35.
3-46.
1) forthe PaxView TB/NTM MPCR-ULFA Kit.
Compared to the Xpert MTB/RIF as a standard reference, thePaxView TB/NTM MPCR-ULFA Kit was found to possess a 92.
5% sensitivity (111/120; 95% CI 87.
8-97.
2), a 90.
8% specificity (179/197; 95% CI 86.
8-94.
8), 86.
0% PPV (111/129; 95% CI 80.
0-92.
0), anda NPV 95.
2% (179/188; 95% CI 92.
2-98.
3).
The PaxView TB/NTM MPCR-ULFA Kit could be a usefulmolecular diagnostic tool to identify MTB in clinical samples in resource-limited countries, as this procedureis more cost-effective and sensitive than the Xpert MTB/RIF, and more convenient than conventional PCRgel electrophoresis approaches.
Related Results
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Background: Molecular examination using Xpert MTB RIF and Xpert MTB RIF Ultra was introduced by WHO in 2010 as a fast and practical supporting examination in detecting Mycobacteriu...
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Abstract
Background
Uganda introduced Xpert® MTB/RIF assay into its TB diagnostic algorithm in January 2012. In July 2018, this...
Comparison evaluation between gene Xpert Mtb/Rif and multiplex PCR for rapid diagnosis of mycobacterium tuberculosis
Comparison evaluation between gene Xpert Mtb/Rif and multiplex PCR for rapid diagnosis of mycobacterium tuberculosis
Abstract
Objective: To evaluate Gene Xpert MTB/RIF and Multiplex PCRfor detection of Mycobacterium tuberculosis and Rifampicin resistance comparing with gold standard MGIT 96...
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
Abstract
Introduction: The value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensiti...
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
Abstract
Background
The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifa...
Survival and infectivity of mycobacterium tuberculosis after aerosolization
Survival and infectivity of mycobacterium tuberculosis after aerosolization
<p dir="ltr">Tuberculosis (TB) remains the leading cause of death by a single infectious organism with over 1.3 million people succumbing to the disease every year. Despite e...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
AbstractThe value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensitive Xpert MTB/RIF Ultra ...

